Afeyan compared the present deployment of AI to the thalidomide tragedy of the 1950s and 1960s, when a drug released without sufficient vetting caused severe birth defects. He argued that waiting for a catastrophe to occur before introducing regulation would repeat the costly historical mistakes of the pharmaceutical industry.
